Normal bladder and urethral pressure ranges measured with e-Sense catheters

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a post‑market observational effort enrolling adults referred for clinic urodynamics to collect pressure data using both e-Sense electronic catheters and standard water‑filled catheters. Resting pressures will be recorded in lying, sitting, and standing positions and pressure values will be measured at intervals during bladder filling. Detrusor and urethral pressures captured by the e-Sense device will be compared to the water‑filled catheter values to define expected normal ranges. The resulting reference values will be provided to clinicians and the device sponsor to support interpretation of e-Sense measurements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects medically indicated for Urodynamic procedure between ages 20-35 or \> 50 years old (equally split male and female)
* Due to aging and giving birth significantly affecting the urethra:
* Female subjects 20-35 should be nulliparous.
* Female subjects \> 50 years old should have given birth to at least one child vaginally. Further caesarian births would not mean exclusion from the study.
* Subjects with range of BMI values
* Subject provides written authorization and/or consent per institution or geographical requirements

Exclusion Criteria:

* Subjects with cognitive or psychiatric conditions that interfere with or precludes direct and accurate communication regarding the study, giving informed consent
* Any anal / rectal symptoms and/or surgery
* Pregnant women
* Subjects with active untreated bladder infections (not including patients with asymptomatic bacteruria)
* Subjects having greater than 300 mL post void residual on the clinic visit uroflowmetry test

Where it's running

• Bristol Urological Institute
  Bristol, United Kingdom Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Silodosin for urinary symptoms in women with MS

  This study tests whether silodosin helps relieve lower urinary tract symptoms in women with multiple sclerosis, compared with a placebo.

  Recruiting Phase 4 Atlantic Health System · Morristown, New Jersey · NCT07614321

• Low-energy shock wave treatment for overactive bladder in women with metabolic syndrome

  This trial tests whether low-energy extracorporeal shock wave therapy (LiESWT) can reduce urgency, daytime frequency, and nighttime urination in women who have metabolic syndrome.

  Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung, Taiwan · NCT07563764

• Comparing bipolar enucleation versus transurethral resection for enlarged prostate outcomes and patient experience

  This trial will test whether bipolar enucleation or standard transurethral resection gives better urinary symptoms, patient experience, and value for men with enlarged prostates who are referred for surgery.

  Recruiting Sykehuset Innlandet HF · Hamar and 1 other locations · NCT07562386

• Urodynamics versus videourodynamics for women with recurrent stress urinary incontinence

  This trial will test whether videourodynamics or standard urodynamics before repeat surgery helps women with recurrent stress urinary incontinence get better treatment outcomes.

  Recruiting University College, London · London · NCT07542080

• Botox injection into the bladder at the time of prostate surgery to reduce overactive bladder symptoms.

  This test looks at whether a Botox shot into the bladder given during TURP or Aquablation helps men with BPH who have overactive bladder symptoms feel better after surgery.

  Recruiting Benaroya Research Institute · Seattle, Washington · NCT07377929

• Combination finasteride plus raloxifene therapy with epigenetic biomarker testing for benign prostate enlargement

  This project will test whether adding raloxifene to finasteride and using epigenetic biomarker tests helps men with benign prostate enlargement who are candidates for finasteride.

  Recruiting Phase 2 Beth Israel Deaconess Medical Center · Boston, Massachusetts · NCT06944145

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.